Pancreatic Cancer Research

ResearcherJilin UniversityNo recent work listed

Minghui Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2251-1496; OpenAlex author ID A5089479809. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. Co-author DOI 10.3389/fonc.2022.904258↗
  2. ZFX Promotes Proliferation and Metastasis of Pancreatic Cancer Cells via the MAPK Pathway. First author DOI 10.1159/000491727↗
  3. microRNA and gene networks in human pancreatic cancer. Co-author DOI 10.3892/ol.2013.1521↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haifeng Zhang · 1 shared paper, 2022 · strength 0.19
  2. Xiao Hu · 1 shared paper, 2022 · strength 0.19
  3. Yu Zeng · 1 shared paper, 2022 · strength 0.19
  4. Yingbin Liu · 1 shared paper, 2018 · strength 0.07
  5. Jun Fei Gu · 1 shared paper, 2018 · strength 0.07
  6. Fei Zhang · 1 shared paper, 2018 · strength 0.07
  7. Xiaoling Song · 1 shared paper, 2018 · strength 0.07
  8. Jianhua Lu · 1 shared paper, 2018 · strength 0.07
  9. Wei Gong · 1 shared paper, 2018 · strength 0.07
  10. Ning Wang · 1 shared paper, 2013 · strength 0.05
  11. Yang Li · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.